最高級の80列、新生。
最高級の80列、新生。
Cerebral Atrophy
Aquilion Prime SP
68-year-old male presented with recurrent headaches. A non-contrast Head CT scan was performed with AIDR 3D, Adaptive Iterative Dose Reduction. Axial and Sagittal images demonstrate cerebral atrophy.
*AAPM Report 96, k-factor 0.0021
*AAPM Report 96, k-factor 0.0021
| Scan Mode | Helical |
| Collimation | 0.5 mm x 40 |
| kVp | 120 |
| mAs | 240 |
| Rotation Time | 0.75 s |
| Scan Range | 156 mm |
| Dose Reduction | AIDR 3D |
| CTDlvol | 57 mGy |
| DLP | 995 mGy·cm |
| Effective Dose* | 2.1 mSv |
Head CT, CTDI 46.3 mgy
Aquilion Prime SP
Brain CT without iodinated contrast was performed with AIDR 3D Enhanced, Adaptive Iterative Dose Reduction, embedded into the protocol and automatically applied to the scan. AIDR 3D Enhanced allowed this case to be scanned with CTDI of 46.3 mGy and DLP of 794.8 mGy.cm. PUREViSION Optics permits the x-ray spectrum to be optimized for low dose and high image quality scanning. Multiplanar Reconstruction (MPR) demonstrates senile cortical atrophy.
*AAPM Report 96, k-factor 0.0021
| Scan Mode | Ultra-Helical |
| Collimation | 0.5 mm x 40 |
| kVp | 120 |
| mAs | SURE Exposure |
| Rotation Time | 0.75 s |
| Scan Range | 152.8 mm |
| Dose Reduction | AIDR 3D Enhanced |
| CTDlvol | 46.3 mGy |
| DLP | 794.3 mGy·cm |
| Effective Dose* | 1.6 mSy |
社名変更のお知らせ: 弊社は2018年1月4日より、東芝メディカルシステムズ株式会社からキヤノンメディカルシステムズ株式会社へ社名を変更いたしました。本Webサイトの一部には、旧社名が表示されている場合がございます。
